Sinekod syrup is shown for symptomatic treatment of cough (including dry) various origin.
Structure
Active ingredient - the butamirat citrate (1 ml of syrup contains 1.5 mg of the butamirat of citrate).
Excipients: sorbite solution (E 420), glycerin, sodium saccharin, benzoic acid (E 210), vanillin, ethanol of 96%, sodium hydroxide of 30%, the water purified.
Contraindication
Hypersensitivity to active or to excipients of medicine.
Route of administration
Recommended dosage:
- children aged from the 3rd up to 6 years - on 5 ml 3 times a day;
- children aged from 6 up to 12 years - on 10 ml 3 times a day;
- children aged from 12 up to 18 years - on 15 ml 3 times a day;
- adult - on 15 ml 4 times a day.
Volumetric glass needs to be washed up and dried up after each use and after use by other person.
Maximum course of treatment without medical prescription should not exceedone week. >
it is desirable for p to use Drug to food.
Feature of application
Pregnant
Safety at use of this syrup during pregnancy and feeding by a breast was not estimated in special researches. It is not necessary to apply Sinekod within the first three months of pregnancy. During other periods of pregnancy this syrup can be applied only on doctor's orders in the presence of direct indications to such treatment. It is unknown, active substance and/or its metabolites gets into breast milk. For reasons of safety it is necessary to weigh carefully advantages and risks of use of this syrup during feeding by a breast. Use of medicine during feeding by a breast perhaps if, according to the doctor, the expected positive effect for mother exceeds potential risk for the child.
Children
to Children up to 3 years do not apply medicine in this dosage form.
Drivers
Seldom Sinekod can cause drowsiness that can have some influence on ability to steer motor transport or to perform work with mechanisms. Therefore when driving or when performing other work demanding vigilance (for example, at control of mechanisms), it is necessary to be careful.
Overdose
Overdose can cause such symptoms: drowsiness, nausea, vomiting, diarrhea, dizziness and arterial hypotonia.
needs to take usual measures for emergency aid: gastric lavage, intake of activated carbon, control of the vital functions of an organism, symptomatic treatment. There is no specific antidote.
Side effects
from nervous system (it is rare: ≥ 1/10000, <1/1000) - drowsiness.
from digestive tract (it is rare: ≥ 1/10000, <1/1000) - nausea, diarrhea.
from the immune system (it is rare: ≥ 1/10000, <1/1000) - an acute anaphylaxis.
from skin and hypodermic fabric (it is rare: ≥ 1/10000, <1/1000) - a Quincke's disease, rash, a small tortoiseshell, an itch.
Storage conditionsto Store
out of children's reach at a temperature not above 30 °C.
Expiration date - 3 years.
Characteristics | |
Active ingredients | Butamirat |
Amount of active ingredient | 1.5 mg/ml |
Applicant | GSK |
Code of automatic telephone exchange | R05DB13 Butamirat |
Interaction with food | To |
Light sensitivity | Not sensitive |
Market status | Original |
Origin | Chemical |
Prescription status | Without prescription |
Primary packing | bottle |
Producer | KONSYYUMER HELSKER S.A GSC. |
Quantity in packing | 200 ml |
Release form | syrup |
Route of administration | Oral |
Sign | Import |
Storage temperature | from 5 °C to 30 °C |
Trade name | Sinekod |
Sinekod syrup 1.5mg/ml fl. 200 ml
- Product Code: 180250
- In Stock
- Ready to ship
-
$31.15